Porto, Italo
 Distribuzione geografica
Continente #
EU - Europa 6.654
NA - Nord America 5.880
AS - Asia 1.895
AF - Africa 28
SA - Sud America 26
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 18
Totale 14.523
Nazione #
US - Stati Uniti d'America 5.859
DE - Germania 3.107
SE - Svezia 1.004
CN - Cina 946
IT - Italia 565
UA - Ucraina 549
SG - Singapore 439
FR - Francia 325
IE - Irlanda 305
GB - Regno Unito 284
ID - Indonesia 202
RU - Federazione Russa 139
FI - Finlandia 128
IN - India 105
TR - Turchia 85
PL - Polonia 72
BE - Belgio 43
JP - Giappone 41
AT - Austria 31
NL - Olanda 28
IR - Iran 19
EU - Europa 18
HK - Hong Kong 18
CA - Canada 17
AU - Australia 15
ES - Italia 12
CH - Svizzera 11
CZ - Repubblica Ceca 10
ET - Etiopia 10
BR - Brasile 9
EG - Egitto 9
LT - Lituania 7
AR - Argentina 6
CO - Colombia 6
TW - Taiwan 6
VN - Vietnam 6
BG - Bulgaria 5
KR - Corea 5
MA - Marocco 5
A2 - ???statistics.table.value.countryCode.A2??? 4
GR - Grecia 4
HR - Croazia 4
MD - Moldavia 4
MY - Malesia 4
NO - Norvegia 4
BD - Bangladesh 3
CI - Costa d'Avorio 3
IL - Israele 3
NZ - Nuova Zelanda 3
QA - Qatar 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
DK - Danimarca 2
HU - Ungheria 2
KG - Kirghizistan 2
LU - Lussemburgo 2
MX - Messico 2
UY - Uruguay 2
AL - Albania 1
BO - Bolivia 1
BS - Bahamas 1
BZ - Belize 1
CL - Cile 1
IQ - Iraq 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MK - Macedonia 1
PE - Perù 1
RS - Serbia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 14.523
Città #
Chandler 1.513
Ashburn 377
San Mateo 338
Jacksonville 327
Singapore 314
Dublin 302
New York 259
Nanjing 217
Nürnberg 216
Jakarta 201
Wilmington 177
Ann Arbor 165
Boston 126
Marseille 122
Dearborn 121
Milan 114
Cattolica 110
Moscow 110
Nanchang 104
Munich 101
Woodbridge 100
Lawrence 93
Beijing 85
Princeton 79
Houston 78
Izmir 71
Lancaster 69
Redwood City 65
Seattle 61
Los Angeles 54
Bremen 52
Fairfield 50
Hebei 49
Mountain View 44
Brussels 42
Detroit 42
Leawood 40
Kunming 38
Shenyang 37
Kraków 36
Rome 35
Changsha 31
University Park 31
Vienna 31
Warsaw 31
Zhengzhou 31
Shanghai 30
Norwalk 27
Redmond 26
Tianjin 26
Boardman 25
Jiaxing 25
Andover 23
Augusta 20
Chicago 20
Helsinki 20
London 20
Hangzhou 18
Pune 18
Washington 16
Cambridge 15
Fremont 15
San Francisco 15
Simi Valley 15
Changchun 14
Tokyo 14
Hong Kong 13
Orange 12
Saint Louis 12
Santa Clara 12
Bari 11
Guangzhou 11
Lanzhou 11
Groningen 10
Indiana 10
Philadelphia 10
Phoenix 10
Toronto 10
Bologna 9
Busto Arsizio 9
Hefei 8
Genova 7
Kish 7
Renton 7
Almere Stad 6
Amsterdam 6
Berlin 6
Bogotá 6
Edinburgh 6
Genoa 6
Jinan 6
Naples 6
Paris 6
Taipei 6
Cairo 5
Frankfurt am Main 5
Melbourne 5
Salé 5
Yellow Springs 5
Ardabil 4
Totale 7.359
Nome #
Comparison of Right and Left Upper Limb Arterial Variants in Patients Undergoing Bilateral Transradial Procedures 218
Frequency domain optical coherence tomography to assess non-ostial left main coronary artery 203
Safety and efficacy of G-CSF in patients with ischemic heart failure: The CORNER (Cell Option for Recovery in the Non-Eligible patients for Revascularization) study. 201
Prospective evaluation of myocardial ischemia related to post-procedural side-branch stenosis in bifurcated lesions treated by provisional approach with drug-eluting stents. 194
The HEART study: a real-world experience using the CID Chrono Carbostent in primary and rescue PCI 187
Baseline C-Reactive Protein Serum Levels and In-Stent Restenosis Pattern After m-TOR Inhibitors Drug-Eluting Stent Implantation 185
Differences in Microparticle Release in Patients With Acute Coronary Syndrome and Stable Angina 182
Renal artery stenting in patients with chronic ischemic heart disease 178
Ticagrelor and preconditioning in patients with stable coronary artery disease (TAPER-S): A randomized pilot clinical trial 172
Management and timing of access-site vascular complications occurring after trans-radial percutaneous coronary procedures 167
Euroscore as predictor of in-hospital mortality after percutaneous coronary intervention 164
Angiographic and clinical outcome of percutaneous coronary intervention for in-stent restenosis of bifurcated lesions 159
Outcome of non-cardiac surgery after stent implantation in the DES era: results of the Surgery After Stent (SAS) registry 151
Cystatin C is associated with an increased coronary atherosclerotic burden and a stable plaque phenotype in patients with ischemic heart disease and normal glomerular filtration rate 150
Angiographic patterns of myocardial reperfusion after primary angioplasty and ventricular remodeling 147
Pre-intervention eosinophil cationic protein serum levels predict clinical outcomes following implantation of drug-eluting stents 144
Vascular complications and access crossover in 10,676 transradial percutaneous coronary procedures 142
Efficacy of contrast medium induced Pd/Pa ratio in predicting functional significance of intermediate coronary artery stenosis assessed by fractional flow reserve: insights from the RINASCI study 140
Procedural and clinical evaluation of the novel zotarolimus-eluting resolute stent in patients with unselected bifurcated coronary stenosis treated by provisional approach: a multicenter registry 139
Euroscore as predictor of in-hospital mortality after percutaneous coronary intervention 139
Angiographically intermediate left main bifurcation disease assessment by frequency domain optical coherence tomography (FD-OCT) 139
Concordance of angiographic and electrocardiographic indexes of microvascular obstruction: myocardial haemorrhage role 138
Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial 133
Prospective randomized comparison of sirolimus- or everolimus-eluting stent to treat bifurcated lesions by provisional approach 130
Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention 130
Case-control registry of excimer laser coronary angioplasty versus distal protection devices in patients with acute coronary syndromes due to saphenous vein graft disease 129
Characterization of microvascular and myocardial damage within perfusion defect area at myocardial contrast echocardiography in the subacute phase of myocardial infarction 128
Impact of gender on clinical outcomes after mTOR-inhibitor drug-eluting stent implantation in patients with first manifestation of ischaemic heart disease 128
Concordance of angiographic and electrocardiographic indexes of microvascular obstruction: myocardial haemorrhage role 126
Eosinophil cationic protein and clinical outcome after bare metal stent implantation 125
Patent foramen ovale and hypercoagulable state in the pathogenesis of acute thrombotic myocardial infarction 125
Procedural and clinical evaluation of the novel zotarolimus-eluting resolute stent in patients with unselected bifurcated coronary stenosis treated by provisional approach: a multicenter registry 123
Are endothelial progenitor cells mobilized by myocardial ischemia or myocardial necrosis? A cardiac magnetic resonance study 122
Coronary bifurcation lesions: to stent one branch or both? A meta-analysis of patients treated with drug eluting stents. 121
Plaque rupture and intact fibrous cap assessed by optical coherence tomography portend different outcomes in patients with acute coronary syndrome 121
Frequency-domain optical coherence tomography findings in patients with bifurcated lesions undergoing provisional stenting 120
Angiographic assessment of myocardial perfusion in Tako-Tsubo syndrome 120
Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the rigenera study). 117
EuroSCORE predicts long-term mortality of unselected patients undergoing percutaneous coronary interventions 112
Clopidogrel-induced neutropenia after coronary stenting: is cilostazol a good alternative? 112
Resolute zotarolimus-eluting stent to treat bifurcated lesions according to the provisional technique: a procedural performance comparison with sirolimus- and everolimus-eluting stents 110
Coronary Atherosclerotic Phenotype and Plaque Healing in Patients with Recurrent Acute Coronary Syndromes Compared with Patients with Long-term Clinical Stability: An in Vivo Optical Coherence Tomography Study 110
Eosinophil cationic protein and clinical outcome after bare metal stent implantation 109
Maximal hyperemia in the assessment of fractional flow reserve: intracoronary adenosine versus intracoronary sodium nitroprusside versus intravenous adenosine: the NASCI (Nitroprussiato versus Adenosina nelle Stenosi Coronariche Intermedie) study 109
Impact of coronary stenting on top of medical therapy and of inclusion of periprocedural infarctions on hard composite endpoints in patients with chronic coronary syndromes: a meta-analysis of randomized controlled trials 109
Parvovirus B19 at the culprit coronary stenosis predicts outcome after stenting 107
Three-dimensional quantitative coronary angiography and quantification of jeopardised myocardium to predict functional significance of intermediate coronary artery stenosis 107
Efficacy of contrast medium induced Pd/Pa ratio in predicting functional significance of intermediate coronary artery stenosis assessed by fractional flow reserve: insights from the RINASCI study 106
Ethanol abolishes ischemic preconditioning in humans 105
Clopidogrel-induced neutropenia after coronary stenting: is cilostazol a good alternative? 104
Predictors of thromboxane levels in patients with non-ST-elevation acute coronary syndromes on chronic aspirin therapy 104
Predictors of periprocedural (type IVa) myocardial infarction, as assessed by frequency-domain optical coherence tomography 103
A current approach to heart failure in Duchenne muscular dystrophy 103
A meta-analysis of first-generation drug-eluting vs bare-metal stents for coronary chronic total occlusion: effect of length of follow-up on clinical outcome 101
Influence of the amount of myocardium subtended by a stenosis on fractional flow reserve 101
Three-dimensional quantitative coronary angiography and quantification of jeopardised myocardium to predict functional significance of intermediate coronary artery stenosis 101
No-reflow reversibility: a study based on serial assessment of multiple biomarkers 100
Baseline inflammatory status and long-term changes in renal function after percutaneous renal artery stenting: A prospective study 99
Impact of drug-eluting balloon (pre- or post-) dilation on neointima formation in de novo lesions treated by bare-metal stent: the IN-PACT CORO trial 99
Left anterior descending artery percutaneous coronary intervention from the right radial access via the left internal mammary artery: A case report 96
Frequency-domain optical coherence tomography assessment of kissing-balloon effects in bifurcated coronary artery lesions undergoing provisional stenting 96
Long-term morphofunctional remodeling of internal thoracic artery grafts: a frequency-domain optical coherence tomography study 95
Coronary Stenosis as an Innocent Bystander in Acute Coronary Syndrome 95
Association between inflammatory biomarkers and in-stent restenosis tissue features: an Optical Coherence Tomography Study 94
Management and timing of access-site vascular complications occurring after trans-radial percutaneous coronary procedures 92
Angiographic assessment of microvascular perfusion--myocardial blush in clinical practice 90
Alterations of Hyaluronan Metabolism in Acute Coronary Syndrome: Implications for Plaque Erosion 88
Differential levels of circulating progenitor cells in acute coronary syndrome patients with a first event versus patients with recurring events 87
Excimer laser for a highly stenotic saphenous vein graft: evidence of debulking by optical coherence tomography 87
Dual role of circulating endothelial progenitor cells in stent struts endothelialisation and neointimal regrowth: a substudy of the IN-PACT CORO trial 87
Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction) 86
Intracoronary microparticles and microvascular obstruction in patients with ST elevation myocardial infarction undergoing primary percutaneous intervention 85
One-year outcomes of consecutive patients treated by endeavor zotarolimus and resolute zotarolimus stents: The impact of polymer coating in drug-eluting stent technology 84
Endothelial progenitor cells, microvascular obstruction, and left ventricular remodeling in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention 84
Trends and Outcomes of Radial Approach in Left-Main Bifurcation Percutaneous Coronary Intervention in the Drug-Eluting Stent Era: A Two-Center Registry 83
Differential levels of circulating progenitor cells in acute coronary syndrome patients with a first event versus patients with recurring events 82
Microparticles in health and disease: small mediators, large role? 82
Quantitative Blush Evaluator accurately quantifies microvascular dysfunction in patients with ST-elevation myocardial infarction: comparison with cardiovascular magnetic resonance 82
Predictors of myocardial microvascular obstruction in patients treated by primary percutaneous coronary intervention and a short ischemic time 79
Radial artery complications occurring after transradial coronary procedures using long hydrophilic-coated introducer sheath: a frequency domain-optical coherence tomography study 78
Morphological-biohumoral correlations in acute coronary syndromes: Pathogenetic implications 78
DESolve novolimus-eluting bioresorbable coronary scaffold failure assessed by frequency-domain optical coherence tomography imaging 78
Blood lactate predicts survival after percutaneous implantation of extracorporeal life support for refractory cardiac arrest or cardiogenic shock complicating acute coronary syndrome: insights from the CareGem registry 78
A case of variant angina in a patient under chronic treatment with sorafenib 77
Outcome of non-cardiac surgery after stent implantation in the DES era: results of the Surgery After Stent (SAS) registry 76
Radial artery intima-media ratio predicts presence of coronary thin-cap fibroatheroma: a frequency domain-optical coherence tomography study 74
Three-year follow-up of patients with bifurcation lesions treated with sirolimus- or everolimus-eluting stents: SEAside and CORpal cooperative study 74
Post-procedural renal microvascular perfusion measured using the Quantitative Blush Evaluator (QuBE) predicts improvement in renal function in patients undergoing percutaneous renal artery stenting 73
Frequency-domain optical coherence tomography findings in patients with bifurcated lesions undergoing provisional stenting 72
Baseline inflammatory status and long-term changes in renal function after percutaneous renal artery stenting: a prospective study 70
EuroSCORE predicts long-term mortality of unselected patients undergoing percutaneous coronary interventions 69
temporal evolution and functional outcome of no reflow: sustained and spontaneously reversible patterns following successful coronary recanalisation 68
Mechanisms, prevention and treatment of distal embolization 68
Data on optical coherence tomography guidance for the management of angiographically intermediate left main bifurcation lesions 68
Clinical impact of suboptimal stenting and residual intrastent plaque/thrombus protrusion in patients with acute coronary syndrome 67
Coronary plaque instability assessed by positron emission tomography and optical coherence tomography 67
The Multi-center Evaluation of the Accuracy of the Contrast MEdium INduced Pd/Pa RaTiO in Predicting FFR (MEMENTOFFR) Study 66
Coronary Stenosis as an Innocent Bystander in Acute Coronary Syndrome 65
Endothelial dysfunction as predictor of angina recurrence after successful percutaneous coronary intervention using second generation drug eluting stents 65
Blood lactate predicts survival after percutaneous implantation of extracorporeal life support for refractory cardiac arrest or cardiogenic shock complicating acute coronary syndrome: insights from the CareGem registry 65
Totale 11.098
Categoria #
all - tutte 59.865
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.865


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.116 0 0 0 0 144 143 192 53 157 114 172 141
2020/20211.198 39 117 24 127 147 97 151 41 174 51 185 45
2021/20221.701 118 115 28 84 109 49 48 304 66 115 302 363
2022/20233.673 432 576 337 571 168 489 164 284 462 63 94 33
2023/20241.792 71 487 54 84 76 348 90 65 28 41 230 218
2024/2025687 89 128 254 165 51 0 0 0 0 0 0 0
Totale 14.809